Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More

被引：90

作者：

Saha, Abinit ^{[1
]}

Sharma, Ashish Ranjan ^{[2
]}

Bhattacharya, Manojit ^{[3
]}

Sharma, Garima ^{[4
]}

Lee, Sang-Soo ^{[2
]}

Chakraborty, Chiranjib ^{[1
]}

机构：

[1] Adamas Univ, Sch Life Sci & Biotechnol, Dept Biotechnol, Barasat Barrackpore Rd, Kolkata 700126, W Bengal, India

[2] Hallym Univ, Chuncheon Sacred Heart Hosp, Inst Skeletal Aging & Orthoped Surg, Chuncheon Si, Gangwon Do, South Korea

[3] Fakir Mohan Univ, Dept Zool, VyasaVihar, Balasore, Odisha, India

[4] Kangwon Natl Univ, Neuropsychopharmacol & Toxicol Program, Coll Pharm, Gangwon Do, South Korea

来源：

ARCHIVES OF MEDICAL RESEARCH | 2020年 / 51卷 / 06期

基金：

新加坡国家研究基金会;

关键词：

SARS-CoV-2; Remdesivir; COVID-19; Therapeutic molecule; GS-5734; EBOLA;

D O I：

10.1016/j.arcmed.2020.05.001

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

COVID-19 is now pandemic throughout the world. Scientist, doctors are searching for effective therapy of this diseases. The remdesivir, an antiviral drug, is appeared as 'molecule of hope' for the treatment of this disease. USFDA gave emergency approval to this drug for the treatment of COVID-19. The molecular mechanism is unknown. In this pa per, we tried to describe the probable molecular mechanism of remdesivir to inhibit the RNA synthesis of SARS-CoV-2. However, more detail mechanism is needed to understand mechanism of action of remdesivir. (c) 2020 IMSS. Published by Elsevier Inc.

引用

页码：585 / 586

页数：2

共 50 条

[31] Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Coelho, Luis
Falcao, Fatima
Povoa, Pedro
Viegas, Erica
Martins, Antonio Pais
Carmo, Eduarda
Fonseca, Candida
Campos, Luis
Mansinho, Kamal
Carmo, Ines
Soares, Joana
Solano, Mariana
Mendes, Dina
Miranda, Ana Claudia
Carvalho, Antonio
Mirco, Ana
Farinha, Helena
Aldir, Isabel
Correia, Jose
[J]. SCIENTIFIC REPORTS, 2023, 13 (01)
[32] Remdesivir (Veklury) for the Treatment of COVID-19 in Hospitalized Patients
Odeti, Shyam
Yellepeddi, Venkata K.
[J]. AMERICAN FAMILY PHYSICIAN, 2021, 104 (02) : 311 - 312
[33] Remdesivir treatment for patients with moderate to severe COVID-19
Hasanoglu, Imran
Guner, Rahmet
Celik, Ilhami
Kanat, Fikret
Batirel, Ayse
Dizman, Gulcin Telli
Eren, Esma
Sevgi, Dilek Yildiz
Bozkurt, Ilkay
Yasar, Kadriye Kart
Senoglu, Sevtap
Kazak, Esra
Karaali, Ridvan
Celikbas, Aysel
Pullukcu, Husnu
Cagatay, Arif Atahan
Unal, Serhat
Erdinc, Sebnem
Tabak, Fehmi
Gul, Ahmet
Alp, Emine
[J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 880 - 887
[34] Addendum to Systematic Review of Remdesivir for the Treatment of COVID-19
Musa, Arif
Warbasse, Elizabeth
Baron, David A.
Pendi, Kasim
Hashemi, Areio
Yousif, Jenna
Blodget, Emily
Stevens, Susan
Aly, Besma
Khambati, Alisha
Kouyoumjian, Sarkis
[J]. WESTERN JOURNAL OF EMERGENCY MEDICINE, 2020, 21 (04) : 742 - 743
[35] Remdesivir for the treatment of COVID-19: author's response
Lee, Todd C.
McDonald, Emily G.
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (01) : 115 - 117
[36] Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature
Musa, Arif
Pendi, Kasim
Hashemi, Areio
Warbasse, Elizabeth
Kouyoumjian, Sarkis
Yousif, Jenna
Blodget, Emily
Stevens, Susan
Aly, Besma
Baron, David A.
[J]. WESTERN JOURNAL OF EMERGENCY MEDICINE, 2020, 21 (04) : 737 - 741
[37] Antiviral treatment for COVID-19: the evidence supporting remdesivir
Richardson, Charlotte
Bhagani, Sanjay
Pollara, Gabriele
[J]. CLINICAL MEDICINE, 2020, 20 (06)
[38] Remdesivir (Veklury) for COVID-19
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1612): : 186 - 188
[39] Remdesivir bei COVID-19
Redaktion Facharztmagazine
[J]. MMW - Fortschritte der Medizin, 2022, 164 (2) : 65 - 65
[40] COVID-19: Is Remdesivir the Cure?
不详
[J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (13)

← 1 2 3 4 5 →